| A | a-site tRNA |
| ABC | ATP-binding-cassette |
| ABC-f | ATP-binding-cassette family |
| CA-MRSA | community-associated methicillin resistance Staphylococcus aureus |
| CLSI | Clinical and Laboratory Standards Institute |
| cMLSB | constitutive macrolides, lincosamides and streptogramin B phenotype |
| E | e-site tRNA |
| Erm | erythromycin resistance methylase |
| EUCAST | European Committee on Antimicrobial Susceptibility Testing |
| FDA | Food and Drug Administration |
| HA-MRSA | hospital-acquired methicillin resistance Staphylococcus aureus |
| hVISA | heterogeneous vancomycin intermediate-resistance Staphylococcus aureus |
| iMLSB | inductive macrolides, lincosamides, and streptogramin B phenotype |
| LA-MRSA | livestock-associated methicillin resistance Staphylococcus aureus |
| MAC-MRSA | Macrolide-resistant methicillin-resistant Staphylococcus aureus |
| MIC | minimal inhibitory concentration |
| MDR | multi-drug resistance |
| MLSB | macrolides, lincosamides and streptogramin B |
| MSB | phenotype of resistance to macrolides and streptogramin B |
| MRSA | methicillin resistance Staphylococcus aureus |
| MSD | membrane spanning domains |
| MSSA | methicillin sensitive Staphylococcus aureus |
| NBD | nucleotide binding domains |
| NPET | nascent peptide exit tunnel |
| ORF | open reading frame |
| P | p-site tRNA |
| PCT | phenyl transferase center |
| PRSA | penicillin resistance Staphylococcus aureus |
| RBS | ribosome binding site |
| TMD | transmembrane domains |
| WHO | World Health Organization |
| VISA | vancomycin intermediate-resistance Staphylococcus aureus |
| VRSA | vancomycin resistance Staphylococcus aureus |